News
-
Contingency management can help retain people in treatment and strengthen abstinence
Fact sheet No 7/2016 (Lisbon, 07.10.2016) Ahead of World Mental Health Day on 10 October, the EMCDDA has published a new review on how contingency management can help treat those with substance use disorders. Read more >> -
Third EMDAS graduation ceremony at the EMCDDA
(Lisbon, 23.09.2016) The third group of students graduating from the European Masters in Drug and Alcohol Studies (EMDAS), will receive their diplomas at a ceremony at the EMCDDA on 23 September. Read more >> -
New ESPAD results: teenage drinking and smoking down, but concerns posed by new drugs and new addictive behaviours
News Release No 10/2016 (Lisbon, 20.09.2016) Smoking and drinking among 15–16-year-old school students are showing signs of decline, but there are concerns over challenges posed by new drugs and new addictive behaviours. Read more >> -
Upcoming ESPAD report on substance use among school students
(Lisbon, 13.09.2016) The latest European data on substance use among 15–16-year-old school students will be released next week (20 September). The findings are based on a 2015 survey in 35 European countries Read more >> -
EMCDDA Director presents the European Drug Report 2016 to members of the Civil Liberties, Justice and Home Affairs (LIBE) Committee of the European Parliament
(Lisbon, 08.09.2016) The Director will present the European Drug Report 2016 on 8 September 2016 to the members of the Civil Liberties, Justice and Home Affairs (LIBE) Committee of the European Parliament. The... Read more >> -
New psychoactive substances: Commission proposes new ban and strengthens the EU's Early Warning System and risk assessment
(Lisbon, 31.08.2016) Today, the European Commission has proposed to subject the new psychoactive substance MDMB-CHMICA (sometimes referred to as ‘Black Mamba’) to control measures across the European Union. Read more >> -
New EMCDDA report sheds light on drug-related hospital emergencies
News Release No 9/2016 (Lisbon, 04.08.2016) Data from hospital emergency departments show that every year in Europe thousands of individuals experience drug-related poisoning and other harms, requiring some kind of medical assistance. Read more >> -
New EMCDDA report shows grounds for hope in treating hepatitis C
News release No 8/2016 (Lisbon, 28.07.2016) Hepatitis C is an infectious disease of the liver caused by the blood-borne hepatitis C virus. In a new report published today on World Hepatitis Day, the EU drugs agency (EMCDDA) looks at new... Read more >> -
European Parliament LIBE Committee members pay fact-finding visit to the EMCDDA
Fact sheet No 6/2016 (Lisbon 18.07.2016, 12.07.2016) Members of the European Parliament Committee on Civil Liberties, Justice and Home Affairs (LIBE) start a two-day visit to the EMCDDA today where they will hear presentations on the agency’s... Read more >> -
EMCDDA Director at German Bundestag hearing on new psychoactive substances
(Lisbon, 06.07.2016) EMCDDA Director Alexis Goosdeel is in Berlin today where he is speaking at a public hearing at the German Parliament (Bundestag) on the issue of new psychoactive substances (NPS). The hearing is... Read more >> -
EMCDDA conference takes stock of project with ENP partner countries
Fact sheet No 5/2016 (Lisbon, 29.06.2016) The EU drugs agency (EMCDDA) is hosting a conference in Lisbon today marking the end of a 30-month technical cooperation project within the framework of the European Neighbourhood Policy (ENP). Read more >> -
Fifth European drugs summer school opens today in Lisbon
Fact sheet No 4/2016 (Lisbon, 27.06.2016) The fifth European drugs summer school — ‘Illicit drugs in Europe: demand, supply and public policies’ — opened today in Lisbon and will run until 8 July. The initiative, organised by ISCTE and the ... Read more >> -
EMCDDA publishes its first report on health responses to new psychoactive substances
News release No 7/2016 (Lisbon, 24.06.2016) In its latest report, released today ahead of International day against drug abuse and illicit trafficking (26 June), the EMCDDA presents its first analysis of the health responses to NPS. Read more >> -
EMCDDA highlights new health risks as products and patterns of use change
News release No 6/2016 (Lisbon, 31.05.2016) Europe’s drug market remains resilient, says the EU drugs agency (EMCDDA) today as it launches in Lisbon its European Drug Report 2016: Trends and Developments, Read more >> -
Speech by Alexis Goosdeel at National Drugs Coordinators’ meeting, Dutch Presidency
(Amsterdam, 02.05.2016) EMCDDA Director, Alexis Goosdeel, attended the EU National Drugs Coordinators' meeting on 'Drugs and Nightlife' in Amsterdam, where he presented his views on developing efficient interventions for... Read more >> -
Coming up: European Drug Report 2016
News release No 5/2016 (Lisbon, 20.04.2016) What drugs are causing the most harm and concern today? What are the most recent developments in drug prevention, treatment and policy? These and other questions will be explored on 31 May in its... Read more >> -
Follow the EMCDDA delegation at UNGASS 2016
(Lisbon, 18.04.2016) The UN General Assembly Special Session (UNGASS) on drugs, taking place from 19–21 April 2016 in New York, is a major political moment and an opportunity for the international community to review and... Read more >> -
EMCDDA to join EU delegation at UNGASS 2016 in New York
Fact sheet No 3/2016 (Lisbon, 18.04.2016) The 2016 UN General Assembly Special Session (UNGASS) on drugs will convene at the UN headquarters in New York from 19–21 April. This meeting represents a major opportunity for the international... Read more >> -
Director's speech: presentation of the EU Drug Markets Report, LIBE Committee, European Parliament, Brussels
(Brussels, 07.04.2016) Dear Chair, Ladies and Gentlemen, It is a great pleasure to present to you today the second EU Drug Markets Report that was launched on Tuesday with Commissioner Avramopoulos and my colleague Rob... Read more >> -
New report highlights wide-ranging impact of EU drug markets on society
(Lisbon, 05.04.2016) Europeans spend at least EUR 24 billion on illicit drugs each year, making it one of the main profit-generating activities for organised criminals in Europe. Read more >> -
Speech by EMCDDA Director on the occasion of the launch of EU Drug Markets Report, Brussels
(Brussels, 05.04.2016) Ladies and Gentlemen, It is a great pleasure to be here today with Commissioner Avramopoulos and with my colleague Rob Wainwright, Director of Europol, to launch the second EU Drug Markets Report. I... Read more >> -
EMCDDA presents latest advances in monitoring illicit drugs in wastewater
News release No 4/2016 (Lisbon, 15.03.2016) The latest advances in the science of wastewater analysis are presented by the EMCDDA today in a new report 'Assessing illicit drugs in wastewater'. Read more >> -
59th Commission on Narcotic Drugs, 14–22 March 2016, Vienna
(Lisbon, 11.03.2016) The United Nations Commission on Narcotic Drugs (CND), the central UN policy-making body in drug-related matters, opens its 59th session in Vienna this month (14–22 March). Read more >> -
Evaluation of the EU Drugs Strategy and Action Plan (2013–2016): public consultation
(Lisbon, 04.03.2016) The EU Drugs Strategy provides a political framework and priorities for action in the field of drug policies for the period 2013–2020. It is structured around two policy fields: drug demand reduction... Read more >> -
Upcoming strategic analysis of the European drug market
News release No 3/2016 (Lisbon, 01.03.2016) Illicit drugs are big business. They are one of the main profit-generating activities of organised crime and are estimated to represent around one-fifth of global crime proceeds. Read more >> -
New EMCDDA report: the internet and drug markets
News release No 2/2016 (Lisbon, 11.02.2016) How do online drug markets function? What technologies do they use? How do they relate to the traditional drug market? How can they be monitored and controlled? Read more >> -
Council of EU representatives visit EMCDDA
News item 2/2016 (Lisbon, 04.02.2016) Representatives of the Justice Affairs Directorate of the General Secretariat of the Council of the EU will visit the EMCDDA on 4 February where they will meet the agency’s Director Alexis Goosdeel... Read more >> -
Director presents EMCDDA strategy and work programme 2016–18 and annual work programme 2016 at European Parliament
(Lisbon, 25.01.2016) The EMCDDA Director will be presenting to members of the Committee for Civil Liberties, Justice and Home Affairs (LIBE) highlights from the EMCDDA strategy and work programme 2016–18 and the 2016... Read more >> -
New EMCDDA insights into naloxone, the overdose antidote that can help save lives
News release No 1/2016 (Lisbon, 18.01.2016) Between 6 000 and 8 000 drug-induced deaths are reported in Europe every year, with opioids, such as heroin, found in most overdose cases. Yet with adequate intervention, using the overdose-reversal... Read more >> -
Registration opens for fifth European drugs summer school
Fact sheet 2/2016 (Lisbon, 08.01.2016) This year the University Institute of Lisbon (ISCTE-IUL) and the EMCDDA will be hosting the fifth European drugs summer school (EDSS) from 27 June to 8 July. Registration opens today... Read more >>